News Releases

Given the complex and rapidly evolving health care system in the United States, medical schools must focus their efforts on training more physician leaders to master the diverse skills needed to navigate emerging challenges in the field, urge leaders from the Perelman School of Medicine at the University of Pennsylvania in a new Perspective piece published today in the New England Journal of Medicine.

Hailing from 28 states and two countries, 100 volunteers and 500 riders in 28 “disease” teams will cycle in the fifth annual Million Dollar Bike Ride, to be held on Sunday, May 20, 2018.

The Melanoma Research Foundation (MRF) is honoring two Penn clinicians for their tireless work in caring for patients. Ari D. Brooks, MD, a professor of Surgery in the Perelman School of Medicine at the University of Pennsylvania, the director of Endocrine and Oncologic Surgery in Penn’s Abramson Cancer Center, and the director of the Integrated Breast Center at Pennsylvania Hospital, will receive the 2018 Humanitarian Award. Suzanne McGettigan, CRNP, a Nurse Practitioner in the Abramson Cancer Center, will receive the Compassionate Care Award.

When the Centers for Medicare and Medicaid Services (CMS) announced controversial policies inviting states to establish work requirements as a condition to receive Medicaid, many in the medical community opposed it.

James Eberwine, PhD, the Elmer Holmes Bobst Professor of Systems Pharmacology and Translational Therapeutics in the Perelman School of Medicine at the University of Pennsylvania, is part of an international team of researchers, who will receive $1.25M over the next three years to better understand oxidative phosphorylation (OxPhos), a biological system that plays a key role in the production of energy, generation of free radicals, and cell death.

After eight years of failed treatment for persistent atrial fibrillation (AF), Janet Szilagyi, 78 of Clayton, New Jersey, became the first patient in the United States to undergo cardiac ablation – a procedure in which an electrophysiologist will scar or destroy tissue in the heart that’s allowing incorrect electrical signals to cause an abnormal heart rhythm – using an intraoperative imaging and mapping system recently cleared by the Food and Drug Administration (FDA).